Brief: Crossject FY net loss widens to 4.3 mln euros
13/03/2015 06:02
March 13 (Reuters) - Crossject SA ALCJ.PA :
* Reports FY net loss of 4.3 million euros ($4.56 million)
versus loss of 1.8 million euros year ago
Source text for Eikon: ID:nHUG1cbtrJ
Further company coverage: ALCJ.PA
($1 = 0.9438 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure